Budgeting a Multi-Week Retatrutide Protocol by Per-Mg Cost
A guide to budgeting a multi-week retatrutide research protocol using per-mg cost, vial concentration, and reconstitution math instead of guesswork.
Reviewed by Marcus Webb, PhD, research pharmacologist ·
Marcus Webb, PhD is a research pharmacologist with a doctorate from Johns Hopkins University and over 12 years of experience in receptor-selective peptide analogs, bioavailability science, and the pharmacoeconomics of emerging therapeutic compounds.
- retatrutide
- cost
- budgeting
- reconstitution
Budgeting for a multi-week retatrutide research protocol based on per-mg cost starts with a single number: the price of the compound divided by the total milligrams in the vial. Everything else in a research budget — how many vials to order, how much bacteriostatic water to use, how many weeks a given order will cover — flows from that one figure. Listings vary widely in vial size, purity claims, and price, which makes per-mg cost the only unit that lets a researcher compare them on equal footing.
Why per-mg cost is the right budgeting unit
A vial price by itself says very little. A 5 mg vial priced higher than a 10 mg vial from another source is not necessarily more expensive per unit of compound — it depends entirely on how much material is inside. Dividing the listed price by the vial’s labeled milligram content produces a per-mg figure that can be lined up across sources, regardless of how each one packages or prices its vials.
Per-mg cost also age well over a multi-week protocol. A single vial price answers “what does this order cost,” but a per-mg figure answers “what does this protocol cost as it scales,” which is the more useful question when a research plan spans several weeks and several vials.
Building the budget: from per-mg cost to a total
A multi-week budget has three inputs: the per-mg cost, the total milligrams the protocol calls for across all weeks, and any fixed costs like shipping that repeat with each order. The core formula is:
Total cost = (per-mg cost × total mg needed) + shipping costs across all orders
The total mg needed is itself a product of the weekly mg figure in a research plan and the number of weeks the protocol runs. A researcher planning around a fixed total budget can invert this: divide the budget by the per-mg cost to find the maximum total milligrams affordable, then divide that by the number of weeks to see what weekly allocation the budget supports.
Worked example: vial cost to weekly allocation
Consider a listing priced at $220 for a 10 mg vial. The per-mg cost is:
$220 ÷ 10 mg = $22 per mg
Suppose a research protocol plan calls for 5 mg of total material per week over a 6-week span. Total material needed:
5 mg/week × 6 weeks = 30 mg
Total cost for that material at $22 per mg:
30 mg × $22 = $660
Since each vial holds 10 mg, the protocol requires 3 vials (30 mg ÷ 10 mg per vial), and $660 ÷ 3 vials also checks out to $220 per vial, confirming the arithmetic is internally consistent. If shipping is charged once per order and the researcher orders all 3 vials together, that shipping cost is added once rather than three times, which is a meaningful budget difference compared to ordering vial-by-vial across separate weeks.
Reconstitution changes concentration, not total cost
Once a vial is purchased, adding bacteriostatic water changes the concentration of the solution but not the total milligrams of compound in the vial, and therefore not the per-mg cost already paid. Concentration is calculated as:
Concentration (mg/mL) = vial mg ÷ mL of bacteriostatic water added
For the 10 mg vial above, adding 2 mL of bacteriostatic water yields a concentration of 5 mg/mL (10 mg ÷ 2 mL). Adding 5 mL instead yields 2 mg/mL (10 mg ÷ 5 mL). Neither choice changes what was paid for the vial — reconstitution volume is a dilution decision, not a cost decision. Where reconstitution volume does affect a budget indirectly is precision: a more concentrated solution means smaller volumes are measured on a U-100 insulin syringe (where 1 mL = 100 units), which can matter for how finely a research plan can be divided across a multi-week schedule without wasting material to measurement rounding.
Comparing listings on a standardized basis
| Vial size | Listed price | Per-mg cost |
|---|---|---|
| 5 mg | $130 | $26.00 |
| 10 mg | $220 | $22.00 |
| 15 mg | $300 | $20.00 |
| 20 mg | $370 | $18.50 |
A pattern common across peptide listings is that larger vials tend to carry a lower per-mg cost, which is why total protocol length matters when budgeting: a short protocol may not use enough material to justify a larger vial’s up-front cost, while a longer multi-week protocol can make the lower per-mg rate of a larger vial the better overall value even though the sticker price is higher. Working from the table above rather than sticker price alone is what keeps the comparison honest.
Accounting for purity and testing documentation
Per-mg cost comparisons are only meaningful when the underlying material is comparable. A listing with a lower per-mg price but no certificate of analysis, or a COA that does not specify a testing method or purity percentage, is not directly comparable to a listing that documents third-party testing. Budgeting research spend is not just about the lowest number per milligram — it is about what that milligram is verified to contain. Where a source publishes a COA, checking the tested purity against the labeled content is a reasonable step before treating that vial’s per-mg cost as equivalent to another vial’s.
Building in a buffer
Multi-week protocols benefit from a small material buffer beyond the strict mg total calculated for the plan, since reconstitution and measurement introduce some unavoidable variance. Budgeting for slightly more than the exact total — enough to cover an extra partial dose or a measurement error — avoids a mid-protocol gap that would otherwise require a rushed reorder, which itself often carries a disproportionate shipping cost relative to the small amount of material needed to close the gap.
Summary
Budgeting for a multi-week retatrutide research protocol comes down to converting every listing into a per-mg cost, multiplying that figure by the total milligrams the protocol plan requires, and adding in shipping and a small material buffer. Reconstitution volume affects concentration and measurement precision but not the underlying cost already paid for the vial. Comparing sources on a standardized per-mg basis, alongside what each source documents about purity, is what turns a set of vial prices into a workable research budget.
For background on the compound referenced in current listings, see a Bayesian network meta-analysis of retatrutide and related agents for weight loss and a phase 2 trial report describing retatrutide’s triple-hormone mechanism. Researchers comparing reconstitution math across multiple vial sizes may also find a dosing and concentration calculator useful for cross-checking figures before finalizing a protocol budget.